المؤلفون: Shuting Zhou, Zhenyu Zhang, Xiaodong Feng, Chengjian Zhao, Lu Jiang

المصدر: Frontiers in Pharmacology, Vol 14 (2023)

مصطلحات موضوعية: lichenoid reactions, Sintilimab Therapy, immune checkpoint inhibitors (ICIs), PD-1 inhibitor, mucocutaneous reactions, immune-related adverse events (irAEs), Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2023.1276788/fullTest; https://doaj.org/toc/1663-9812Test

الوصول الحر: https://doaj.org/article/ccabe5ebe6c049d0952309c06a65c42cTest

المؤلفون: Huaju Yang, Zheran Liu, Ruidan Li, Rendong Huang, Xingchen Peng

المصدر: Frontiers in Pharmacology, Vol 14 (2023)

مصطلحات موضوعية: immune checkpoint Inhibitors (ICIs), aspirin, immune-related adverse events (irAEs), cancer, US food and drug administration adverse event reporting system (FAERS) database, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2023.1259628/fullTest; https://doaj.org/toc/1663-9812Test

الوصول الحر: https://doaj.org/article/8805dbe63eae4b7aa500f1b4b30882efTest

المؤلفون: Xue-lin Zou, Wei-yong Chen, Guang-yan Zhang, Hua Ke, Qiu-hong Yang, Xiao-bo Li

المصدر: Frontiers in Pharmacology, Vol 12 (2021)

مصطلحات موضوعية: immune checkpoint inhibitors (ICIs), incidence, risk factors, thromboembolism, prognosis, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2021.747075/fullTest; https://doaj.org/toc/1663-9812Test

الوصول الحر: https://doaj.org/article/6f643805f9cf4647b9fe532a3cf11118Test

المؤلفون: Qiu-hong Yang, Xue-lin Zou, Wei-yong Chen, Guang-yan Zhang, Hua Ke, Xiao-bo Li

المصدر: Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)

مصطلحات موضوعية: Pharmacology, Oncology, medicine.medical_specialty, business.industry, Immune checkpoint inhibitors, Incidence (epidemiology), Standard treatment, Cancer, RM1-950, Review, thromboembolism, medicine.disease, Internal medicine, Intervention (counseling), Early prediction, incidence, medicine, risk factors, Pharmacology (medical), In patient, Therapeutics. Pharmacology, prognosis, Adverse effect, business, immune checkpoint inhibitors (ICIs)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1752ddabf1aadbbecaec93557e58deb6Test
https://doi.org/10.3389/fphar.2021.747075Test